InMed Pharmaceuticals (NASDAQ:INM) reported quarterly losses of $(0.91) per share. The company reported $469.78 thousand in sales this quarter. This is a 77.22 percent increase over sales of $265.09 thousand the same period last year.
InMed Pharmaceuticals Q2 EPS $(0.91), Sales $469.78K Up From $265.09K YoY
InMed Pharmaceuticals (NASDAQ:INM) reported quarterly losses of $(0.91) per share. The company reported $469.78 thousand in sales this quarter. This is a 77.22 percent increase over sales of $265.09 thousand the
